icon-    folder.gif   Conference Reports for NATAP  
 
  Presented at the 22nd Conference of the Asian Pacific Association for the Study of the Liver (APASL)
Taipei, Taiwan
February 16-19, 2012
Back grey_arrow_rt.gif
 
 
 
DRUG INTERACTION PROFILE OF TELAPREVIR
 
 
  Reported by Jules Levin
22nd Conference of the Asian Pacific Association for the Study of the Liver (APASL), Taipei, Taiwan, February 16-19, 2012
 
Varun Garg*1, Robert S Kauffman1, Maria Beumont2, Rolf van Heeswijk2 1Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA; 2Janssen Infectious Diseases BVBA, Beerse, Belgium

APSL1.gif

APSL2.gif

APSL3.gif

APSL4.gif

APSL5.gif

APSL6.gif

APSL7.gif